BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 11030468)

  • 1. Proficient and cost-effective approaches for the prevention and treatment of venous thrombosis and thromboembolism.
    Bick RL
    Drugs; 2000 Sep; 60(3):575-95. PubMed ID: 11030468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Towards evidence-based guidelines for the prevention of venous thromboembolism: systematic reviews of mechanical methods, oral anticoagulation, dextran and regional anaesthesia as thromboprophylaxis.
    Roderick P; Ferris G; Wilson K; Halls H; Jackson D; Collins R; Baigent C
    Health Technol Assess; 2005 Dec; 9(49):iii-iv, ix-x, 1-78. PubMed ID: 16336844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylaxis against venous thromboembolism in orthopedic surgery.
    Liu LT; Ma BT
    Chin J Traumatol; 2006 Aug; 9(4):249-56. PubMed ID: 16849000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Home versus in-patient treatment for deep vein thrombosis.
    Othieno R; Okpo E; Forster R
    Cochrane Database Syst Rev; 2018 Jan; 1(1):CD003076. PubMed ID: 29315455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing, preventing, and treating venous thromboembolism: evidence-based approaches.
    Nutescu EA
    Am J Health Syst Pharm; 2007 Jun; 64(11 Suppl 7):S5-13. PubMed ID: 17519445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Results of an economic model to assess the cost-effectiveness of enoxaparin, a low-molecular-weight heparin, versus warfarin for the prophylaxis of deep vein thrombosis and associated long-term complications in total hip replacement surgery in the United States.
    Botteman MF; Caprini J; Stephens JM; Nadipelli V; Bell CF; Pashos CL; Cohen AT
    Clin Ther; 2002 Nov; 24(11):1960-86; discussion 1938. PubMed ID: 12501885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic analysis of low-dose heparin vs the low-molecular-weight heparin enoxaparin for prevention of venous thromboembolism after colorectal surgery.
    Etchells E; McLeod RS; Geerts W; Barton P; Detsky AS
    Arch Intern Med; 1999 Jun; 159(11):1221-8. PubMed ID: 10371230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interventions for preventing venous thromboembolism following abdominal aortic surgery.
    Bani-Hani MG; Al-Khaffaf H; Titi MA; Jaradat I
    Cochrane Database Syst Rev; 2008 Jan; 2008(1):CD005509. PubMed ID: 18254082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety of perioperative subcutaneous heparin for prophylaxis of venous thromboembolism in patients undergoing craniotomy.
    Macdonald RL; Amidei C; Lin G; Munshi I; Baron J; Weir BK; Brown F; Erickson RK; Hekmatpanah J
    Neurosurgery; 1999 Aug; 45(2):245-51; discussion 251-2. PubMed ID: 10449068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of venous thromboembolism: a systematic review for a practice guideline.
    Segal JB; Streiff MB; Hofmann LV; Thornton K; Bass EB
    Ann Intern Med; 2007 Feb; 146(3):211-22. PubMed ID: 17261856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dermatan sulfate versus unfractionated heparin for the prevention of venous thromboembolism in patients undergoing surgery for cancer. A cost-effectiveness analysis.
    Attanasio E; Russo P; Carunchio G; Caprino L
    Pharmacoeconomics; 2001 Jan; 19(1):57-68. PubMed ID: 11252546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thromboprophylaxis for trauma patients.
    Barrera LM; Perel P; Ker K; Cirocchi R; Farinella E; Morales Uribe CH
    Cochrane Database Syst Rev; 2013 Mar; (3):CD008303. PubMed ID: 23543562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heparin, low molecular weight heparin and physical methods for preventing deep vein thrombosis and pulmonary embolism following surgery for hip fractures.
    Handoll HH; Farrar MJ; McBirnie J; Tytherleigh-Strong G; Milne AA; Gillespie WJ
    Cochrane Database Syst Rev; 2002; (4):CD000305. PubMed ID: 12519540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention and diagnosis of venous thromboembolism in critically ill patients: a Canadian survey.
    Cook D; McMullin J; Hodder R; Heule M; Pinilla J; Dodek P; Stewart T;
    Crit Care; 2001 Dec; 5(6):336-42. PubMed ID: 11737922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enoxaparin. A pharmacoeconomic appraisal of its use in thromboembolic prophylaxis after total hip arthroplasty.
    Dunn CJ; Goa KL
    Pharmacoeconomics; 1996 Aug; 10(2):179-90. PubMed ID: 10163420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prevention of venous thromboembolism in polytraumatized patients. Epidemiology and importance].
    Venet C; Berger C; Tardy B; Viallon A; Decousus H; Bertrand JC
    Presse Med; 2000 Jan; 29(2):68-75. PubMed ID: 10682030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Venous thromboembolism: deep venous thrombosis and pulmonary embolism in a neurosurgical population.
    Khaldi A; Helo N; Schneck MJ; Origitano TC
    J Neurosurg; 2011 Jan; 114(1):40-6. PubMed ID: 20815694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reviparin: a review of its efficacy in the prevention and treatment of venous thromboembolism.
    Wellington K; McClellan K; Jarvis B
    Drugs; 2001; 61(8):1185-209. PubMed ID: 11465877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of venous thromboembolism: recommendations based on the International Consensus and the American College of Chest Physicians Sixth Consensus Conference on Antithrombotic Therapy.
    Haas S
    Clin Appl Thromb Hemost; 2001 Jul; 7(3):171-7. PubMed ID: 11441977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A probabilistic cost-effectiveness analysis of enoxaparin versus unfractionated heparin for the prophylaxis of deep-vein thrombosis following major trauma.
    Lynd LD; Goeree R; Crowther MA; O'Brien BJ
    Can J Clin Pharmacol; 2007; 14(2):e215-26. PubMed ID: 17652767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.